In Brief: Abbott
Executive Summary
Abbott: Hospital division markets Fentanyl Oralet and is copromoting Purdue Pharma's OxyContin (oxycodone controlled-release). The June 10 issue of "The Pink Sheet" (T&G-3) misidentified the fentanyl product marketed by the company...